BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
4.180
+0.010 (0.24%)
At close: Feb 6, 2026, 4:00 PM EST
4.150
-0.030 (-0.72%)
After-hours: Feb 6, 2026, 7:24 PM EST
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of $25.95 million as of February 6, 2026. Its market cap has increased by 44.97% in one year.
Market Cap
25.95M
Enterprise Value
14.85M
1-Year Change
44.97%
Ranking
Category
Stock Price
$4.18
Market Cap Chart
Since February 24, 2021, BriaCell Therapeutics's market cap has decreased from $26.00M to $25.95M, a decrease of -0.20%. That is a compound annual growth rate of -0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 7.90M | -41.04% |
| Dec 31, 2025 | 13.40M | -46.40% |
| Dec 31, 2024 | 25.00M | -73.26% |
| Dec 29, 2023 | 93.50M | 37.91% |
| Dec 30, 2022 | 67.80M | -46.74% |
| Dec 31, 2021 | 127.30M | 389.62% |
| Feb 24, 2021 | 26.00M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroSense Therapeutics | 28.85M |
| Barinthus Biotherapeutics | 28.60M |
| Lixte Biotechnology Holdings | 28.31M |
| Cue Biopharma | 27.54M |
| TuHURA Biosciences | 27.29M |
| Skye Bioscience | 27.27M |
| AEON Biopharma | 26.19M |
| Exicure | 26.13M |